During the past decade, Ctro Inv en Artritis y Osteoporosis SC conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 9 clinical trials were completed, i.e. on average, 128.6% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 7 clinical trials were completed. i.e. 700% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ctro Inv en Artritis y Osteoporosis SC" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Genentech, Inc." with 2 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "Sandoz" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ctro Inv en Artritis y Osteoporosis SC" #1 collaborator was "Hexal AG" with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Ctro Inv en Artritis y Osteoporosis SC" are "Rheumatoid Arthritis" (6 trials), "Axial Spondyloarthritis" (1 trials), "Obesity" (1 trials), "Overweight" (1 trials) and "Psoriatic Arthritis" (1 trials). Many other conditions were trialed in "Ctro Inv en Artritis y Osteoporosis SC" in a lesser frequency.

Most popular intervention types in "Ctro Inv en Artritis y Osteoporosis SC" are "Drug" (8 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Adalimumab" (2 trials), "GDC-0853" (2 trials), "Ixekizumab" (2 trials) and "Adalimumab - GP2017" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ctro Inv en Artritis y Osteoporosis SC" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Ctro Inv en Artritis y Osteoporosis SC". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Ctro Inv en Artritis y Osteoporosis SC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ctro Inv en Artritis y Osteoporosis SC, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".